Suppr超能文献

住院期间体重变化可预测急性失代偿性心力衰竭患者的死亡率。

The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure.

作者信息

Komaki Tomo, Miura Shin-Ichiro, Arimura Tadaaki, Shiga Yuhei, Morii Joji, Kuwano Takashi, Imaizumi Satoshi, Kitajima Ken, Iwata Atsushi, Morito Natsumi, Yahiro Eiji, Fujimi Kanta, Matsunaga Akira, Saku Keijiro

机构信息

Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan; Department of Laboratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.

Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan; Department of Molecular Cardiovascular Therapeutics, Fukuoka University School of Medicine, Fukuoka, Japan.

出版信息

J Clin Med Res. 2017 Mar;9(3):200-206. doi: 10.14740/jocmr2890w. Epub 2017 Jan 25.

Abstract

BACKGROUND

In our experience, the change in body weight (BW) during hospitalization varies greatly in patients with acute decompensated heart failure (HF). Since the clinical significance of a change in BW is not clear, we investigated whether a change in BW could predict mortality.

METHODS

We retrospectively enrolled 130 patients (72 males; aged 68 ± 10 years) who were hospitalized due to acute decompensated HF and followed for 2 years after discharge. The change in the BW index during hospitalization (ΔBWI) was calculated as (BW at hospital admission minus BW at hospital discharge)/body surface area at hospital discharge.

RESULTS

The patients were divided into quartiles according to ΔBWI, and the 2-year mortality rates in the quartiles with the lowest, second, third and highest ΔBWI were 18.8%, 12.1%, 3.1% and 9.1%, respectively. In a multivariate Cox proportional hazards analysis after adjusting for variables with a P value less than 0.05, ΔBWI was independently associated with 2-year mortality (P = 0.0002), and the quartile with the lowest ΔBWI had a higher relative risk (RR) for 2-year mortality than the quartile with the highest ΔBWI (RR: 7.46, 95% confidence interval: 1.03 - 53.99, P = 0.04).

CONCLUSION

In conclusion, ΔBWI was significantly associated with 2-year mortality after discharge, which indicates that ΔBWI might be a simple predictor of prognosis in acute decompensated HF.

摘要

背景

根据我们的经验,急性失代偿性心力衰竭(HF)患者住院期间体重(BW)变化差异很大。由于体重变化的临床意义尚不清楚,我们研究了体重变化是否可以预测死亡率。

方法

我们回顾性纳入了130例因急性失代偿性HF住院的患者(72例男性;年龄68±10岁),并在出院后随访2年。住院期间体重指数变化(ΔBWI)计算为(入院体重减去出院体重)/出院时体表面积。

结果

根据ΔBWI将患者分为四分位数,ΔBWI最低、第二、第三和最高四分位数的2年死亡率分别为18.8%、12.1%、3.1%和9.1%。在对P值小于0.05的变量进行校正后的多因素Cox比例风险分析中,ΔBWI与2年死亡率独立相关(P = 0.0002),ΔBWI最低的四分位数2年死亡率的相对风险(RR)高于ΔBWI最高的四分位数(RR:7.46,95%置信区间:1.03 - 53.99,P = 0.04)。

结论

总之,ΔBWI与出院后2年死亡率显著相关,这表明ΔBWI可能是急性失代偿性HF预后的一个简单预测指标。

相似文献

1
The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure.
J Clin Med Res. 2017 Mar;9(3):200-206. doi: 10.14740/jocmr2890w. Epub 2017 Jan 25.
3
The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
J Heart Lung Transplant. 2014 Apr;33(4):404-11. doi: 10.1016/j.healun.2013.12.005. Epub 2013 Dec 16.
4
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
J Am Coll Cardiol. 2007 May 15;49(19):1943-50. doi: 10.1016/j.jacc.2007.02.037. Epub 2007 Apr 30.

引用本文的文献

2
Construction of risk prediction model for hyponatremia in patients with acute decompensated heart failure.
BMC Cardiovasc Disord. 2023 Oct 26;23(1):520. doi: 10.1186/s12872-023-03557-5.
3
Development of a model predicting cardiac events in heart failure patients with decreased renal function: a retrospective study.
Int J Clin Pharm. 2023 Feb;45(1):210-219. doi: 10.1007/s11096-022-01502-8. Epub 2022 Nov 21.
4
Associations of weight changes with all-cause, cancer and cardiovascular mortality: A prospective cohort study.
Public Health Pract (Oxf). 2020 Dec 11;2:100065. doi: 10.1016/j.puhip.2020.100065. eCollection 2021 Nov.

本文引用的文献

1
Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease.
Heart Vessels. 2016 Oct;31(10):1643-9. doi: 10.1007/s00380-015-0775-9. Epub 2015 Nov 28.
5
Incorporating common biomarkers into the clinical management of heart failure.
Curr Heart Fail Rep. 2013 Dec;10(4):450-7. doi: 10.1007/s11897-013-0165-5.
7
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
Circ Heart Fail. 2012 Sep 1;5(5):602-9. doi: 10.1161/CIRCHEARTFAILURE.112.966960. Epub 2012 Aug 16.
8
Eplerenone in patients with systolic heart failure and mild symptoms.
N Engl J Med. 2011 Jan 6;364(1):11-21. doi: 10.1056/NEJMoa1009492. Epub 2010 Nov 14.
9
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.
J Am Coll Cardiol. 2007 Jul 3;50(1):40-7. doi: 10.1016/j.jacc.2007.02.067. Epub 2007 Jun 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验